Alignment Healthcare, Inc. $ALHC Shares Purchased by Raymond James Financial Inc.

Key Points

• Raymond James Financial Inc. increased its stake in Alignment Healthcare by 31.1%, owning a total of 206,174 shares valued at approximately $3.84 million.
• Several hedge funds, including Vanguard Group and Millennium Management, significantly boosted their investments in Alignment Healthcare, indicating strong institutional interest.
• Alignment Healthcare recently reported $1.02 billion in revenue for the quarter, surpassing analysts' expectations, and achieved $0.07 earnings per share, exceeding the consensus estimate of a loss.

Raymond James Financial Inc. lifted its holdings in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 31.1% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 206,174 shares of the company's stock after purchasing an additional 48,901 shares during the quarter. Raymond James Financial Inc. owned 0.10% of Alignment Healthcare worth $3,839,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the business. MCF Advisors LLC grew its holdings in Alignment Healthcare by 87.6% during the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock worth $40,000 after acquiring an additional 1,011 shares in the last quarter. Skandinaviska Enskilda Banken AB publ acquired a new stake in shares of Alignment Healthcare during the 1st quarter worth approximately $42,000. Amalgamated Bank lifted its position in shares of Alignment Healthcare by 21.6% during the 1st quarter. Amalgamated Bank now owns 3,466 shares of the company's stock valued at $65,000 after buying an additional 616 shares in the last quarter. Voloridge Investment Management LLC purchased a new position in shares of Alignment Healthcare during the 4th quarter valued at approximately $189,000. Finally, Regal Partners Ltd purchased a new position in shares of Alignment Healthcare during the 1st quarter valued at approximately $194,000. 86.19% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

ALHC has been the topic of several recent research reports. Wall Street Zen lowered Alignment Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, August 10th. KeyCorp raised Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price objective for the company in a research report on Monday, August 25th. Stephens upgraded shares of Alignment Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Barclays upgraded shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and boosted their price target for the stock from $9.00 to $13.00 in a report on Thursday, July 31st. Finally, Zacks Research raised Alignment Healthcare to a "hold" rating in a report on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, Alignment Healthcare currently has a consensus rating of "Moderate Buy" and an average price target of $18.83.

Alignment Healthcare Price Performance

Alignment Healthcare stock traded down $0.10 during midday trading on Wednesday, reaching $16.38. 2,558,790 shares of the company were exchanged, compared to its average volume of 3,018,912. The company has a market capitalization of $3.24 billion, a price-to-earnings ratio of -58.53 and a beta of 1.17. The firm's 50-day simple moving average is $14.27 and its 200-day simple moving average is $15.47. Alignment Healthcare, Inc. has a 1 year low of $8.82 and a 1 year high of $21.06. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.66 and a current ratio of 1.66.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of ($0.07) by $0.14. The company had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The firm's revenue was up 49.0% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.13) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, analysts anticipate that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Insider Activity

In related news, insider Christopher J. Joyce sold 15,491 shares of the company's stock in a transaction that occurred on Thursday, July 31st. The stock was sold at an average price of $16.01, for a total transaction of $248,010.91. Following the sale, the insider directly owned 374,531 shares of the company's stock, valued at approximately $5,996,241.31. This represents a 3.97% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Andreas P. Wagner sold 12,032 shares of the stock in a transaction on Monday, August 25th. The stock was sold at an average price of $16.47, for a total value of $198,167.04. Following the completion of the sale, the insider directly owned 192,043 shares in the company, valued at $3,162,948.21. This represents a 5.90% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 425,923 shares of company stock worth $6,068,022 over the last quarter. Corporate insiders own 6.60% of the company's stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.